A detailed history of New York State Common Retirement Fund transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 1,712,565 shares of GILD stock, worth $161 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,712,565
Previous 1,958,365 12.55%
Holding current value
$161 Million
Previous $134 Million 6.86%
% of portfolio
0.19%
Previous 0.18%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$66.59 - $83.99 $16.4 Million - $20.6 Million
-245,800 Reduced 12.55%
1,712,565 $144 Million
Q2 2024

Jul 31, 2024

SELL
$63.15 - $72.88 $870,143 - $1 Million
-13,779 Reduced 0.7%
1,958,365 $134 Million
Q1 2024

May 07, 2024

SELL
$71.58 - $87.29 $5.73 Million - $6.99 Million
-80,057 Reduced 3.9%
1,972,144 $144 Million
Q4 2023

Feb 01, 2024

SELL
$73.27 - $83.09 $10.9 Million - $12.4 Million
-149,304 Reduced 6.78%
2,052,201 $166 Million
Q3 2023

Nov 07, 2023

SELL
$73.94 - $80.67 $4.66 Million - $5.08 Million
-63,011 Reduced 2.78%
2,201,505 $165 Million
Q2 2023

Aug 07, 2023

SELL
$76.01 - $86.7 $1.84 Million - $2.1 Million
-24,171 Reduced 1.06%
2,264,516 $175 Million
Q1 2023

May 02, 2023

SELL
$77.31 - $88.08 $8.33 Million - $9.49 Million
-107,694 Reduced 4.49%
2,288,687 $190 Million
Q4 2022

Jan 30, 2023

BUY
$62.32 - $89.47 $2.69 Million - $3.86 Million
43,158 Added 1.83%
2,396,381 $206 Million
Q3 2022

Nov 08, 2022

SELL
$59.54 - $68.01 $6.72 Million - $7.67 Million
-112,812 Reduced 4.57%
2,353,223 $145 Million
Q2 2022

Aug 04, 2022

SELL
$57.72 - $65.01 $2.44 Million - $2.75 Million
-42,251 Reduced 1.68%
2,466,035 $152 Million
Q1 2022

May 05, 2022

BUY
$57.92 - $72.58 $190,440 - $238,643
3,288 Added 0.13%
2,508,286 $149 Million
Q4 2021

Feb 02, 2022

BUY
$64.88 - $73.64 $4.36 Million - $4.95 Million
67,209 Added 2.76%
2,504,998 $182 Million
Q3 2021

Nov 02, 2021

SELL
$67.69 - $73.03 $5.39 Million - $5.81 Million
-79,576 Reduced 3.16%
2,437,789 $170 Million
Q2 2021

Aug 02, 2021

SELL
$63.47 - $69.35 $4.05 Million - $4.42 Million
-63,773 Reduced 2.47%
2,517,365 $173 Million
Q1 2021

May 11, 2021

SELL
$60.0 - $68.46 $445,740 - $508,589
-7,429 Reduced 0.29%
2,581,138 $167 Million
Q4 2020

Feb 08, 2021

SELL
$56.65 - $64.55 $9.2 Million - $10.5 Million
-162,447 Reduced 5.9%
2,588,567 $151 Million
Q3 2020

Nov 05, 2020

SELL
$62.1 - $78.08 $8.91 Million - $11.2 Million
-143,488 Reduced 4.96%
2,751,014 $174 Million
Q2 2020

Aug 07, 2020

SELL
$72.34 - $84.0 $23.6 Million - $27.5 Million
-326,790 Reduced 10.14%
2,894,502 $223 Million
Q1 2020

May 06, 2020

SELL
$62.63 - $80.22 $9.44 Million - $12.1 Million
-150,689 Reduced 4.47%
3,221,292 $241 Million
Q4 2019

Feb 05, 2020

SELL
$61.62 - $67.78 $2.44 Million - $2.68 Million
-39,591 Reduced 1.16%
3,371,981 $219 Million
Q3 2019

Nov 07, 2019

SELL
$62.51 - $69.0 $2.6 Million - $2.87 Million
-41,576 Reduced 1.2%
3,411,572 $216 Million
Q2 2019

Aug 09, 2019

SELL
$61.87 - $69.38 $2.6 Million - $2.92 Million
-42,100 Reduced 1.2%
3,453,148 $233 Million
Q1 2019

May 08, 2019

BUY
$62.53 - $70.05 $231,361 - $259,185
3,700 Added 0.11%
3,495,248 $227 Million
Q4 2018

Feb 08, 2019

SELL
$60.54 - $79.0 $6.09 Million - $7.95 Million
-100,613 Reduced 2.8%
3,491,548 $218 Million
Q3 2018

Nov 07, 2018

SELL
$71.28 - $78.92 $3.56 Million - $3.95 Million
-50,000 Reduced 1.37%
3,592,161 $277 Million
Q2 2018

Aug 10, 2018

SELL
$64.88 - $75.68 $8.88 Million - $10.4 Million
-136,875 Reduced 3.62%
3,642,161 $258 Million
Q1 2018

May 10, 2018

SELL
$72.84 - $88.8 $3.05 Million - $3.71 Million
-41,817 Reduced 1.09%
3,779,036 $285 Million
Q3 2017

Nov 06, 2017

SELL
$72.11 - $85.47 $4.94 Million - $5.85 Million
-68,461 Reduced 1.76%
3,820,853 $310 Million
Q2 2017

Aug 11, 2017

BUY
N/A
3,889,314
3,889,314 $275 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.